Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa

被引:0
|
作者
Bulterys, Michelle A. [1 ,2 ,3 ]
Njuguna, Irene [3 ,4 ]
Mahy, Mary [5 ]
Gulaid, Laurie A. [6 ]
Powis, Katheen M. [7 ,8 ,9 ]
Wedderburn, Catherine J. [10 ]
John-Stewart, Grace [2 ,3 ]
机构
[1] 3980 15th Ave NE, Seattle, WA 98195 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA USA
[3] Univ Washington, Dept Global Hlth, Seattle, WA USA
[4] Kenyatta Natl Hosp, Nairobi, Kenya
[5] UNAIDS, Geneva, Switzerland
[6] UNICEF, Eastern & Southern Afr Reg Off, Nairobi, Kenya
[7] Harvard Med Sch, Boston, MA USA
[8] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[9] Massachusetts Gen Hosp, Dept Internal Med & Pediat, Boston, MA USA
[10] Univ Cape Town, Dept Pediat & Child Hlth, Cape Town, South Africa
关键词
CHEU; children who are HIV-exposed uninfected; HEU; neurodevelopment; perinatal HIV exposure; sub-Saharan Africa;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The population of 16 million children exposed to HIV and uninfected (CHEU) under 15 years of age continues to expand rapidly, and the estimated prevalence of CHEU exceeds 20% in several countries in sub-Saharan Africa with high HIV prevalence. Some evidence suggests that CHEU experience suboptimal neurodevelopmental outcomes compared to children born to women without HIV. In this commentary, we discuss the latest research on biologic and socio-behavioural factors associated with neurodevelopmental outcomes among CHEU.Discussion: Some but not all studies have noted that CHEU are at risk of poorer neurodevelopment across multiple cognitive domains, most notably in language and motor skills, in diverse settings, ages and using varied assessment tools. Foetal HIV exposure can adversely influence infant immune function, structural brain integrity and growth trajectories. Foetal exposure to antiretrovirals may also influence outcomes. Moreover, general, non-CHEU-specific risk factors for poor neurodevelopment, such as preterm birth, food insecurity, growth faltering and household violence, are amplified among CHEU; addressing these factors will require multi-factorial solutions. There is a need for rigorous harmonised approaches to identify children at the highest risk of delay. In high-burden HIV settings, existing maternal child health programmes serving the general population could adopt structured early child development programmes that educate healthcare workers on CHEU-specific risk factors and train them to conduct rapid neurodevelopmental screening tests. Community-based interventions targeting parent knowledge of optimal caregiving practices have shown to be successful in improving neurodevelopmental outcomes in children and should be adapted for CHEU.Conclusions: CHEU in sub-Saharan Africa have biologic and socio-behavioural factors that may influence their neurodevelopment, brain maturation, immune system and overall health and wellbeing. Multidisciplinary research is needed to disentangle complex interactions between contributing factors. Common environmental and social risk factors for suboptimal neurodevelopment in the general population are disproportionately magnified within the CHEU population, and it is, therefore, important to draw on existing knowledge when considering the socio-behavioural pathways through which HIV exposure could impact CHEU neurodevelopment. Approaches to identify children at greatest risk for poor outcomes and multisectoral interventions are needed to ensure optimal outcomes for CHEU in sub-Saharan Africa.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Tuberculosis is important problem in children with HIV infection in sub-Saharan Africa
    Maher, D
    BRITISH MEDICAL JOURNAL, 1996, 313 (7056): : 562 - 563
  • [42] Disclosure of HIV Status to Children in Sub-Saharan Africa: A Systematic Review
    Doat, Abdul-Razak
    Negarandeh, Reza
    Hasanpour, Marzieh
    MEDICINA-LITHUANIA, 2019, 55 (08):
  • [43] Estimating HIV incidence in sub-Saharan Africa
    Nsanzimana, Sabin
    Mills, Edward J.
    LANCET HIV, 2023, 10 (03): : E146 - E148
  • [44] Combating HIV and AIDS in sub-Saharan Africa
    Manfrin, V
    LANCET, 2001, 357 (9265): : 1364 - 1365
  • [45] The HIV/AIDS epidemic in sub-Saharan Africa
    Anglaret, X
    Salamon, R
    M S-MEDECINE SCIENCES, 2004, 20 (05): : 593 - 598
  • [46] Criminalisation of HIV transmission in sub-Saharan Africa
    不详
    REPRODUCTIVE HEALTH MATTERS, 2009, 17 (34) : 191 - 191
  • [47] Miscarriage of HIV epidemiology in sub-Saharan Africa
    Potterat, JJ
    Brewer, D
    Brody, S
    AIDS, 2006, 20 (06) : 955 - 956
  • [48] The challenge of HIV/AIDS in Sub-Saharan Africa
    Gilks, CF
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1999, 33 (02): : 180 - 184
  • [49] Serodiscordancy and HIV prevention in sub-Saharan Africa
    Celum, Connie
    Baeten, Jared M.
    LANCET, 2013, 381 (9877): : 1519 - 1521
  • [50] HIV and kidney disease in sub-Saharan Africa
    Fabian, June
    Naicker, Saraladevi
    NATURE REVIEWS NEPHROLOGY, 2009, 5 (10) : 591 - 598